Table 1.
Demographic and clinical characteristics in relation to death rate and occurrence of cardiovascular events
| Parameter | Deceased (n = 9) | Survivors (n = 70) | P value | CV event (n = 14) | Other (n = 65) | P value | |
|---|---|---|---|---|---|---|---|
| Males/females, n | 6/3 | 35/35 | 0.346† | 8/6 | 33/32 | 0.62† | |
| Mean age (±SD), years | 75.67±6.67 | 70.97±6.79 | 0.075‡ | 70.86±7.911 | 71.21±6.26 | 0.88‡ | |
| Prior myocardial infarction | 0 | 1 (1.40) | 0.89# | 0 | 1 (1.50) | 0.82# | |
| Prior PCI | 0 | 2 (2.90) | 0.78# | 0 | 2 (3.00) | 0.68# | |
| Atrial fibrillation | 1 (11.10) | 9 (12.90) | 0.88# | 3 (21.40) | 7 (10.7) | 0.368# | |
| Prior CV event | 0 | 5 (7.10) | 0.92# | 1 (7.10) | 4 (6.20) | 0.63# | |
| Peripheral arterial disease | 0 | 1 (1,40) | 0.89# | 1 (7.10) | 0 | 0.17# | |
| Hypertension | 4 (44.40) | 58 (82.90) | 0.03# | 13 (92.90) | 50 (76.90) | 0.29† | |
| Diabetes mellitus | 0 | 23 (32.90) | 0.099# | 7 (50.00) | 16 (24.60) | 0.11† | |
| FH of cardiac disease | 7 (77.80) | 35 (50.00) | 0.22† | 9 (64.30) | 34 (52.30) | 0.56† | |
| Creatinine (mean ± SD) | Type of surgery | 83.77±12.76 | 91.29±26.09 | 0.27” | 110.83±24.14 | 85.87±22.98 | 0.0011 |
| Type of surgery | |||||||
| Orthopedic | 0 | 25 (35.70) | 0,051# | 4 (28.60) | 20 (30.80) | 1.000# | |
| Thoracic | 0 | 4 (5.70) | 0.908# | 3 (21.40) | 1 (1.50) | 0.016# | |
| Abdominal | 9 (100.00) | 40 (57.10) | 0.011 | 7 (50.00) | 43 (65.30) | 0.365 | |
| Other | 0 | 1 (1.40) | 1.000 | 0 | 1 (1.50) | 1.000 | |
| NYHA | |||||||
| Class I–II | 4 (44.40) | 63 (90.00) | 0.001† | 12 (85.70) | 55 (84.60) | 0.934† | |
| Class III–IV | 5 (55.60) | 7 (10.00) | 2 (14.30) | 10 (15.40) | |||
| ASA classification | |||||||
| II | 5 (62.50) | 43 (61.40 | 0.084† | 5 (38.50) | 42 (64.60) | 0.132† | |
| III | 2 (25.00) | 27 (38.60) | 8 (61.50) | 21 (32.30) | |||
| IV | 1 (12.50) | 0 | 0 | 1 (1.50) | |||
| Acute heart failure | 0 | 2 (2.85) | 0.78# | – | – | – | |
| Pulmonary edema | 0 | 3 (4.28) | 0.62# | ||||
| New atrial fibrillation | 0 | 2 (2.85) | 0.78# | ||||
| MR-proADM (mean ± SD) | 1.31±1.23 | 0.74±0.50‖ | 0.01 | 1.34±1.02 | 0.67±0.43 | «i>0.001‖ | |
| hsTnT (mean ± SD) | 15.02±19.13 | 9.96±17.92‖ | 0.21 | 12.78±14.62 | 9.90±18.43 | 0.04‖ | |
Numbers (%) are shown unless indicated otherwise. PCI, percutaneous coronary intervention; CV, cardiovascular; FH, family history; MR-proADM, midregional pro-adrenomedullin; hsTnT, high-sensitivity troponin T; NYHA, New York Heart Association; ASA, American Society of Anesthesiologists.
†
χ2 test
‡
t test
‖
Mann-Whitney test
#
Fisher exact test.